Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization-Reference-Cited by-同舟云学术

Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization

Published:2009-12-14 Issue:9 Volume:29 Page:1303-1315
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Sirvent A,Bénistant C,Pannequin J,Veracini L,Simon V,Bourgaux J-F,Hollande F,Cruzalegui F,Roche S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2009450.pdf

Reference47 articles.

1. Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D . (2005). Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J 24: 1686–1695.

2. Bénistant C, Bourgaux J, Chapuis H, Mottet N, Roche S, Bali J . (2001). The C-terminal Src kinase is a tumour antigen in human carcinoma. Cancer Res 61: 1415–1420.

3. Boggon TJ, Eck MJ . (2004). Structure and regulation of Src family kinases. Oncogene 23: 7918–7927.

4. Boureux A, Furstoss O, Simon V, Roche S . (2005). c-Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and c-myc expression induced by growth factors. J Cell Sci 118: 3717–3726.

5. Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P et al. (2000). Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 191: 1591–1604.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A renaissance for YES in cancer;Oncogene;2023-10-17

2. CSK-mediated signalling by integrins in cancer;Frontiers in Cell and Developmental Biology;2023-07-07

3. Regulation, targets and functions of CSK;Frontiers in Cell and Developmental Biology;2023-06-16

4. Apoptosis regulation by the tyrosine-protein kinase CSK;Frontiers in Cell and Developmental Biology;2022-12-12

5. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy;Life Sciences;2022-11